最新动态
RESOURCES
19
11/2024
nMECA Technology Synthesizes mRNA with 100-Fold Reduction in dsRNA Impurities
PixelBiosciences GmbH' nMECA technology significantly reduces double-stranded RNA impurities in mRNA synthesis by 100-fold, offering a groundbreaking approach to safer and more effective mRNA therapeutics.
check the details
12
10/2024
After receiving gene therapy for a rare disease, seven children develop blood cancer
Among 67 children treated with Bluebird Bio's gene therapy for a rare neurological disease, seven have developed blood cancer so far, with one child unfortunately passing away.
check the details
26
09/2024
Ultra-compact TnpB gene editing tool with an editing efficiency of up to 75%
The TnpB system is not only small in size but also possesses powerful gene-editing capabilities, bringing a new breakthrough to gene-editing technology.
check the details
27
06/2024
Major Breakthrough in RNA Synthesis Technology: Achieving 300nt Length
PixelBiosciences GmbH Co., Ltd. is dedicated to the research and development of RNA synthesis. Recently, our company has achieved a remarkable breakthrough in the field of RNA synthesis, successfully synthesizing RNA molecules with a length of 300nt. This advancement not only demonstrates our leading position in technology but also brings new possibilities for biomedical research and applications.
check the details
24
06/2024
New Breakthrough in Gene Editing: eePASSIGE System
Recently, David Liu's team has made another breakthrough in gene editing technology. The new system, eePASSIGE, can insert exogenous fragments up to 10kb in length, with an integration efficiency 16 times higher than previous systems.
check the details
19
06/2024
Enzymatic synthesis of 200nt RNA
PixelBiosciences GmbH Co., Ltd. has made progress in long-chain RNA synthesis, and successfully achieved the enzymatic synthesis of 200nt RNA.
check the details
